XML 12 R1.htm IDEA: XBRL DOCUMENT v3.25.0.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2024
Feb. 14, 2025
Jun. 28, 2024
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Entity Registrant Name ZIMMER BIOMET HOLDINGS, INC.    
Entity Central Index Key 0001136869    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Large Accelerated Filer    
Entity Common Stock, Shares Outstanding   199,063,164  
Entity Public Float     $ 22,228,595,506
Entity Shell Company false    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Interactive Data Current Yes    
Entity File Number 001-16407    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 13-4151777    
Entity Address, Address Line One 345 East Main Street    
Entity Address, City or Town Warsaw    
Entity Address, State or Province IN    
Entity Address, Postal Zip Code 46580    
City Area Code 574    
Local Phone Number 373-3333    
Documents Incorporated by Reference

Document

 

Form 10-K

Portions of the Proxy Statement with respect to the 2025 Annual Meeting of Stockholders

 

Part III
   
Document Annual Report true    
Document Transition Report false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Auditor Name PricewaterhouseCoopers LLP    
Auditor Location Chicago, Illinois    
Auditor Firm ID 238    
Auditor Opinion [Text Block]

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Zimmer Biomet Holdings, Inc. and its subsidiaries (the "Company") as of December 31, 2024 and 2023, and the related consolidated statements of earnings, of comprehensive income (loss), of stockholders’ equity and of cash flows for each of the three years in the period ended December 31, 2024, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended December 31, 2024 appearing under Item 15(a)(2) (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

    
Common Stock [Member]      
Document Information [Line Items]      
Trading Symbol ZBH    
Security Exchange Name NYSE    
Title of 12(b) Security Common Stock, $0.01 par value    
2.425% Notes due 2026 [Member]      
Document Information [Line Items]      
Trading Symbol ZBH 26    
Security Exchange Name NYSE    
Title of 12(b) Security 2.425% Notes due 2026    
1.164% Notes due 2027 [Member]      
Document Information [Line Items]      
Trading Symbol ZBH 27    
Security Exchange Name NYSE    
Title of 12(b) Security 1.164% Notes due 2027    
3.518% Notes due 2032 [Member]      
Document Information [Line Items]      
Trading Symbol ZBH 32    
Security Exchange Name NYSE    
Title of 12(b) Security 3.518% Notes due 2032